Clinical Trial Update: Study of Neoadjuvant Treatment in Patients With Pancreatic Cancer That is Potentially Resectable [Phase 2]

View source ↗

Summary

A Phase 2 neoadjuvant trial for potentially resectable pancreatic cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Institut Català d'Oncologia | Conditions: Pancreatic Cancer | Phase 2 | Status: TERMINATED